Walk the plant
Every feature starts at a train with a chemist, not in a backlog.
Learn moreAbout
Polymorra exists because the step that decides whether a drug substance is releasable — crystallization — is the least autonomous step in the entire pharmaceutical supply chain.
Built for the plants that make the world’s small molecules
Why now
In-line PAT became standard in new API plants, edge GPUs became cheap enough to sit beside a crystallizer, and foundation models became good enough to reason over spectra, images, and documents together.
What we believe
Nobody hands control of a GMP batch to software on a promise. So we built the audit trail before the autopilot, the shadow mode before the control loop, and the validation package before the sales deck.
Why it matters
Market figures are internal estimates from our TAM/SAM/SOM analysis. Product performance figures are design targets. [ASPIRATIONAL]
The autonomous loop
Polymorra closes the loop around the reaction mass and the crystal — the two things a conventional DCS cannot actually see.
Fuse Raman, FBRM, PVM in-situ imaging, NIR, and reactor telemetry into a live picture of the reaction mass, slurry, and solids.
Plan the react-and-charge, crystallize-and-seed, and isolate-and-dry moves for this batch against the target polymorph, particle size, and purity.
Run with adaptive control: cooling and antisolvent profile, seeding, supersaturation, agitation, addition rate, and endpoint.
Predict polymorph, particle size and habit, impurity profile, and yield in-line — before offline XRPD and HPLC confirm it.
Optimize yield, solvent use, cycle time, and reprocessing risk across the campaign, then flag off-spec and polymorph risk early.
Write an immutable Part 11 record; every chemist correction trains the site model and compounds the data moat.
Roadmap
Directional, and marked as such. [ASPIRATIONAL]
Perception and assist-mode control on crystallizer trains with design partners.
Reaction, isolation, drying, and review by exception across every train in a site.
Lab-to-plant crystallization prediction as a standard part of route introduction.
Fleet-level optimization across sites, with models that improve everywhere as each plant corrects them.
How we work
Every feature starts at a train with a chemist, not in a backlog.
Learn moreAspirational statements are labelled. Estimates are labelled. Trust compounds.
Learn moreIf we are unsure, the DCS keeps control and the batch continues.
Learn moreA few design partners with real engineering attention beats a wide pilot graveyard.
Learn moreAccelerated computing
Perception at the edge, reasoning in the cloud, and a reactor-and-crystallizer twin in between.
Stack
Plant-edge inference per reactor or crystallizer train: PVM crystal-image models, FBRM feature extraction, Raman and NIR soft sensors, anomaly and safety classifiers. [ASPIRATIONAL]
Stack
Low-latency perception and sensor-stream preprocessing for in-situ imaging and PAT spectra inside validated control windows.
Stack
Route-specific polymorph, impurity, particle-size, endpoint, and batch-reasoning models served with validated version locks and rollback.
Stack
Reactor-and-crystallizer twin plus synthesis of rare crystallization faults — oiling-out, fouling, seed drift, wrong-polymorph nucleation. [ASPIRATIONAL]
Stack
Telemetry ETL at campaign scale, plus scheduling, solvent recovery, and crystallization-profile optimization.
Stack
Fine-tuned chemistry-process and batch-record reasoning trained on de-identified design-partner data and chemist corrections. [ASPIRATIONAL]
Trust & compliance
Polymorra is engineered for regulated drug-substance production: grounded outputs, immutable audit trails, graduated autonomy, and validation documentation from day one.
Immutable, validated audit log for every agent perception, recommendation, and control action, with e-signature-ready review flows.
Change control, validated model versioning, and deployment documentation designed for drug-substance manufacturing.
SOC 2 Type I in progress, Type II on the roadmap; SSO/RBAC, encryption in transit and at rest. [ASPIRATIONAL]
Per-tenant isolation of routes, recipes, spectra, and crystal images. No cross-tenant training. On-prem option.
Shadow → assist → bounded auto-control. Every autonomy level is explicitly configured, bounded, and revocable.
Every recommendation cites the spectra, images, telemetry, SOP, or specification it was derived from.
Inference runs on-site so control loops survive network loss; cloud is for training, fleet, and analytics.
Chemist and QA checkpoints are first-class: approve, correct, or reject — and every correction trains the models.
Voices from the plant
Composite quotes from design-partner discovery interviews. [PLACEHOLDER — to be replaced with named references post-pilot]
“The crystallization step is where our campaigns live or die. Seeing supersaturation, particle size, and predicted polymorph in one place — and having the profile adjust itself — is what we have wanted for twenty years.”
“We do not want another dashboard. We want the batch to come out right and the record to be reviewable by exception. That is the only pitch that gets past QA.”
“Tech transfer is our bottleneck. If the twin can predict the plant crystal from the lab crystal, that is worth more than the software costs.”
Start with one crystallizer or reactor train. Prove polymorph, yield, and reprocessing ROI in a validation-friendly pilot. Then expand across the plant.